• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Clin Exp Pediatr . Hepcidin and other obesity-related factors affecting BNT162b2 response in children and adolescents over a 6-month period

tetano

Editor, Senior Moderator
Clin Exp Pediatr

. 2026 Sep 30.
doi: 10.3345/cep.2026.01298. Online ahead of print.

Hepcidin and other obesity-related factors affecting BNT162b2 response in children and adolescents over a 6-month period​


Anthie Damianaki 1 , Antonios Marmarinos 2 , Margaritis Avgeris 2 , Dimitrios Gourgiotis 2 , Elpis-Athina Vlachopapadopoulou 3 , Marietta Charakida 4 , Maria Tsolia 4 , Lydia Kossiva 4

Affiliations Expand

Free article

Abstract​


Background: Obesity causes chronic inflammation and metabolic dysregulation of the immune response and increases an individual's susceptibility to severe infection.


Purpose: This study aimed to evaluate the effect of an increased body mass index (BMI), obesity-associated biomarkers, and habitual factors on immune responses following BNT162b2 vaccination in a pediatric population over a 6-month period.


Methods: In this prospective, single-center cohort study, the participants received a 2-dose regimen of the BNT16 2b2 mRNA vaccine. Anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) immunoglobulin G (IgG) and neutralizing antibody (Ab) levels were measured before vaccination (T0), 14 days after vaccination (T1), and 6 months after the second dose (T2). Baseline anthropometric and biochemical assessments including BMI measurements were performed at T0. Lifestyle characteristics were evaluated using a standardized questionnaire administered at baseline.


Results: T2 SARS-CoV-2 neutralizing Ab levels were significantly lower in overweight or obese participants (P= 0.02). Among the other biochemical markers, hepcidin, and leptin levels were significantly correlated with BMI (P= 0.004 and P<0.001, respectively). The main biochemical parameters that were inversely correlated with T1 IgG and neutralizing titers were uric acid (P=0.007, P<0.001), fasting serum glucose-to-plasma insulin ratio (P=0.02 and P=0.02), and hepcidin (P=0.01 and P=0.01). Passive smoking was associated with lower T2 IgG titers (P=0.04). Higher uric acid levels and a lower KIDMED index were associated with reduced T2 SARS-CoV-2 neutralizingtiters (P=0.005 and P=0.02, respectively). Reactogenicity was significantly correlated with BMI and age (P=0.03 and P= 0.02, respectively), whereas higher hepcidin and uric acid levels were associated with the presence of local and systemic adverse effects, respectively (P=0.008 and P= 0.02, respectively).


Conclusion: Our findings suggest that obesity-related environmental and behavioral factors may be associated with humoral immune responses during 6 months of follow-up.

Keywords: BNT162b2 vaccine; Hepcidin; Mediterranean diet; Obesity; Secondhand smoking.
 
Back
Top Bottom